4//SEC Filing
Levitz Michael L 4
Accession 0001171843-23-001597
CIK 0000898437other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 4:52 PM ET
Size
13.8 KB
Accession
0001171843-23-001597
Insider Transaction Report
Form 4
Levitz Michael L
EVP, CFO, Treasurer
Transactions
- Tax Payment
Common Stock
2023-03-09$26.91/sh−1,303$35,064→ 23,559 total - Exercise/Conversion
Restricted Stock Unit
2023-03-09−4,439→ 4,438 totalExercise: $0.00→ Common Stock (4,439 underlying) - Exercise/Conversion
Common Stock
2023-03-09+4,439→ 24,862 total - Award
Restricted Stock Unit
2023-03-09+17,624→ 17,624 totalExercise: $0.00→ Common Stock (17,624 underlying) - Award
Stock Option (Right to Buy)
2023-03-09+38,475→ 38,475 totalExercise: $29.60Exp: 2033-03-09→ Common Stock (38,475 underlying)
Footnotes (7)
- [F1]Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
- [F2]Reflects an aggregate of 1,303 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023.
- [F3]Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
- [F4]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
- [F5]Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
- [F6]The premium priced stock options vest in three equal annual installments beginning on March 9, 2024.
- [F7]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001468019
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 4:52 PM ET
- Size
- 13.8 KB